Answers are grounded in this paper and cite their sources.
This study provides the end-of-study results on the durability of seroprotection response in a trial comparing 2- and 3-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG) vs 3-dose hepatitis B vaccine with an aluminum hydroxide adjuvant.
No takes yet. Share an insight, caveat, or question.
Marks et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: